Outsourced Pharma

@OutsourcedPharm

Offering readers a deeper exploration and understanding of the relationships between service providers and their Bio and Pharma sponsors.

Vrijeme pridruživanja: prosinac 2015.

Tweetovi

Blokirali ste korisnika/cu @OutsourcedPharm

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @OutsourcedPharm

  1. Hospitals To Serve Up IVs, And Now APIs?

    Poništi
  2. Cheating In The Lab: 3 Data Integrity Pitfalls To Avoid In Laboratory Operations By Kip Wolf, Tunnell Consulting

    Poništi
  3. The Global CDMO Model: Value Creation Is Not Just A Matter Of Integrating The Pieces By Brian Scanlan, managing partner, Freedom Bioscience Partners

    Poništi
  4. Tips For Improving Your Batch Record Review Process By Danielle DeLucy, ASA Training & Quality Consulting, LLC

    Poništi
  5. Biopharma's Technology Scouts: Time To Look At CDMOs, Too?

    Poništi
  6. Biopharma's Technology Scouts: Time To Look At CDMOs, Too?

    Poništi
  7. Cheating In The Lab: 3 Data Integrity Pitfalls To Avoid In Laboratory Operations By Kip Wolf, Tunnell Consulting

    Poništi
  8. Hospitals To Serve Up IVs, And Now APIs?

    Poništi
  9. Tips For Improving Your Batch Record Review Process By Danielle DeLucy, ASA Training & Quality Consulting, LLC

    Poništi
  10. The Global CDMO Model: Value Creation Is Not Just A Matter Of Integrating The Pieces By Brian Scanlan, managing partner, Freedom Bioscience Partners

    Poništi
  11. Identifying Outliers In Process Data Using Visual And Analytical Techniques By Mark Durivage, Quality Systems Compliance LLC

    Poništi
  12. Innovation Envy: Surfing California For Next Biopharma Wave

    Poništi
  13. Hospitals To Serve Up IVs, And Now APIs?

    Poništi
  14. The Global CDMO Model: Value Creation Is Not Just A Matter Of Integrating The Pieces By Brian Scanlan, managing partner, Freedom Bioscience Partners

    Poništi
  15. Cheating In The Lab: 3 Data Integrity Pitfalls To Avoid In Laboratory Operations By Kip Wolf, Tunnell Consulting

    Poništi
  16. Cheating In The Lab: 3 Data Integrity Pitfalls To Avoid In Laboratory Operations By Kip Wolf, Tunnell Consulting

    Poništi
  17. Biopharma's Technology Scouts: Time To Look At CDMOs, Too?

    Poništi
  18. Hospitals To Serve Up IVs, And Now APIs?

    Poništi
  19. Renovating An Existing Biotech Plant To Accommodate A Higher-Titer Product By Erich H. Bozenhardt and Herman F. Bozenhardt

    Poništi
  20. The Global CDMO Model: Value Creation Is Not Just A Matter Of Integrating The Pieces By Brian Scanlan, managing partner, Freedom Bioscience Partners

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·